About Us

Corporate Overview

RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of gastrointestinal and infectious diseases management.

Our three FDA-approved drugs are promoted in the U.S. by a dedicated and experienced sales team, focused on driving increasing revenues.

We have also built an exciting, advanced and largely de-risked R&D pipeline of proprietary late-stage clinical development drug candidates addressing major unmet medical needs.

Our Mission

Our mission is to deliver extraordinary medicines that help people live extraordinary lives. RedHill is focused on advancing gastrointestinal and infectious diseases management through innovation, dedication and a collective mindset of delivering on our promises.